Agenus (AGEN) News Today → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free AGEN Stock Alerts $16.60 +0.04 (+0.24%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 4, 2024 | businesswire.comAgenus Announces Virtual Annual Shareholders MeetingJune 2, 2024 | americanbankingnews.comAgenus (NASDAQ:AGEN) Stock Crosses Above Two Hundred Day Moving Average of $12.85June 1, 2024 | marketbeat.comAgenus (NASDAQ:AGEN) Stock Passes Above 200-Day Moving Average of $12.85Agenus (NASDAQ:AGEN) Stock Passes Above 200 Day Moving Average of $12.85May 30, 2024 | investorplace.comMedical Moonshots: 3 Biotech Stocks Set to SkyrocketMay 29, 2024 | seekingalpha.comAgenus: Multiple Milestones In The Second Half Of 2024May 27, 2024 | investorplace.com7 Biotech Stocks to Put on Your Breakthrough RadarMay 25, 2024 | markets.businessinsider.comBuy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study ResultsMay 24, 2024 | businesswire.comAgenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 24, 2024 | marketbeat.comAgenus (NASDAQ:AGEN) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $40.00 target price on shares of Agenus in a report on Friday.May 23, 2024 | businesswire.comBreakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual MeetingMay 23, 2024 | businesswire.comAgenus to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceMay 22, 2024 | fool.com3 Magnificent Growth Stocks to Buy Hand Over FistMay 18, 2024 | uk.investing.comAgenus sets FDA meeting for cancer therapy pathMay 16, 2024 | finance.yahoo.comFDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal CancerMay 16, 2024 | businesswire.comFDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal CancerMay 15, 2024 | insidermonkey.comMiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comShort Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 25.1%Agenus Inc. (NASDAQ:AGEN - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,240,000 shares, an increase of 25.1% from the April 15th total of 2,590,000 shares. Based on an average daily trading volume, of 795,200 shares, the days-to-cover ratio is currently 4.1 days. Currently, 16.8% of the company's stock are sold short.May 10, 2024 | markets.businessinsider.comBuy Rating for Agenus Inc. on Strong Financial Position and Promising Clinical MilestonesMay 10, 2024 | marketbeat.comAgenus Inc. Forecasted to Earn Q2 2024 Earnings of ($3.10) Per Share (NASDAQ:AGEN)Agenus Inc. (NASDAQ:AGEN - Free Report) - Equities researchers at HC Wainwright raised their Q2 2024 earnings per share estimates for Agenus in a report issued on Tuesday, May 7th. HC Wainwright analyst E. Bodnar now anticipates that the biotechnology company will post earnings of ($3.10) per shaMay 9, 2024 | seekingalpha.comAgenus GAAP EPS of -$3.04 beats by $0.18, revenue of $28M misses by $19.17MMay 8, 2024 | finance.yahoo.comAgenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comAgenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 8, 2024 | finance.yahoo.comAgenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...May 7, 2024 | washingtonpost.comAgenus: Q1 Earnings SnapshotMay 7, 2024 | msn.comAGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | fool.comAgenus (AGEN) Q1 2024 Earnings Call TranscriptMay 7, 2024 | marketbeat.comAgenus (NASDAQ:AGEN) Rating Reiterated by HC WainwrightHC Wainwright reiterated a "buy" rating and set a $40.00 target price on shares of Agenus in a research note on Tuesday.May 7, 2024 | finance.yahoo.comAgenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic DevelopmentsMay 7, 2024 | businesswire.comAgenus Reports First Quarter 2024 ResultsMay 7, 2024 | businesswire.comLigand and Agenus Enter Into $100 Million Royalty Financing AgreementMay 1, 2024 | msn.comWhat to Make of Agenus Stock (NASDAQ:AGEN) Post Reverse Stock SplitMay 1, 2024 | finance.yahoo.comAgenus Regains Compliance with Nasdaq Minimum Bid Price RequirementApril 30, 2024 | seekingalpha.comTime Is Running Out For Agenus To Raise CashApril 30, 2024 | marketbeat.comAgenus (AGEN) Scheduled to Post Earnings on TuesdayAgenus (NASDAQ:AGEN) will be releasing earnings before the market opens on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587670)April 29, 2024 | msn.comCompare with S&P 500 Growth Index SGD Total Return (500GST)April 28, 2024 | fool.comUp 40%: Is This Red-Hot Growth Stock Still a Buy?April 28, 2024 | fool.comUp 40%: Is This Red-Hot Growth Stock Still a Buy?April 27, 2024 | finance.yahoo.comAgenus Inc. (AGEN)April 25, 2024 | marketbeat.comAgenus Inc. (NASDAQ:AGEN) Short Interest UpdateAgenus Inc. (NASDAQ:AGEN - Get Free Report) saw a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 2,590,000 shares, a drop of 94.6% from the March 31st total of 47,720,000 shares. Approximately 13.0% of the company's stock are short sold. Based on an average daily trading volume, of 665,300 shares, the days-to-cover ratio is presently 3.9 days.April 24, 2024 | finance.yahoo.comBotensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual MeetingApril 23, 2024 | benzinga.comTop 2 Health Care Stocks Which Could Rescue Your Portfolio This Month - Agenus (NASDAQ:AGEN), MultiPlan (NYSE:MPLN)April 23, 2024 | businesswire.comAgenus to Provide First Quarter 2024 Financial Report and Corporate UpdateApril 13, 2024 | nasdaq.comCommit To Purchase Agenus At $1, Earn 2607.1% Annualized Using OptionsApril 12, 2024 | markets.businessinsider.comSmall-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns LoomApril 12, 2024 | nasdaq.comAgenus Updates Phase 1 Data Of BOT/BAL Therapy In MSS Metastatic Colorectal CancerApril 12, 2024 | markets.businessinsider.comAgenus Stock Falls After Reporting Updated Phase 1 Data On Colorectal Cancer TherapyApril 12, 2024 | msn.comAgenus reports updated Phase 1 data on colorectal cancer therapyApril 12, 2024 | marketbeat.comAgenus (NASDAQ:AGEN) Reaches New 12-Month Low at $8.10Agenus (NASDAQ:AGEN) Reaches New 52-Week Low at $8.10April 12, 2024 | finance.yahoo.comAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal CancerApril 12, 2024 | businesswire.comAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. AGEN Media Mentions By Week AGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGEN News Sentiment▼0.000.76▲Average Medical News Sentiment AGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGEN Articles This Week▼13▲AGEN Articles Average Week Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sutro Biopharma News Poseida Therapeutics News Adaptimmune Therapeutics News Athira Pharma News Precision BioSciences News Aligos Therapeutics News BioCryst Pharmaceuticals News MannKind News Innoviva News Ironwood Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGEN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored